Ultrasound (US)-guided fine-needle aspiration biopsy (FNA) was performed on 268 thyroid nodules (135 palpable, 133 nonpalpable) in 210 patients with various thyroid conditions; 62 nodules also had palpation-guided FNA. Surgical pathology was obtained in 67 malignant nodules and 32 benign nodules. Although the initial failure rate for palpation-guided FNA (12 of 62) was significantly higher than that for US-guided FNA (10 of 268) (p < 0.001), sensitivity (96%), specificity (91%), accuracy (94%), and positive (96%) and negative predictive values (91%) of US-guided FNA for malignancy (n = 99) were not significantly different from those (88%, 90%, 88%, 95%, and 75%, respectively) of palpation-guided FNA (n = 34) for those nodules where an adequate biopsy was obtained. US-guided FNA established a correct diagnosis in 20 of 22 patients with nonpalpable malignancy and in another nodule in the opposite thyroid lobe in 16 of 17 patients with thyroid malignancy. This procedure determined the correct cancer staging in 19 of 21 patients. US-guided FNA can reliably (1) select a patient who needs surgery and (2) avoid unnecessary surgery. This technique will help determine a cancer staging and institute an appropriate treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcu.1870220904DOI Listing

Publication Analysis

Top Keywords

us-guided fna
16
palpation-guided fna
12
thyroid nodules
8
fine-needle aspiration
8
aspiration biopsy
8
fna
8
patients thyroid
8
cancer staging
8
thyroid
5
us-guided
5

Similar Publications

Background: Neck ultrasound (US) and serum thyroglobulin (Tg) measurements are mainstays of long-term differentiated thyroid cancer (DTC) surveillance. Given the high sensitivity of serum Tg, we aimed to assess the utility of neck US in DTC patients who underwent total thyroidectomy and have undetectable serum Tg.

Methods: We performed a retrospective cohort analysis of DTC patients who underwent a total thyroidectomy at our institution (2010-2023) and received US-guided fine needle aspiration (FNA) during their surveillance.

View Article and Find Full Text PDF

Background: US guided sampling is a validated diagnostic approach for non-thyroid deep head and neck masses.

Aim: To describe the setting of a clinician-driven Lump Clinic and analyze a monoinstitutional 7-year database of 849 patients undergoing US-guided sampling.

Methods: FNA with Rapid OnSite Evalutation (ROSE) was the first diagnostic step.

View Article and Find Full Text PDF

Background: Lymphoma arises from transformed lymphoid cells. Although surgical excision biopsy is the standard diagnostic tool for patients with lymphoma, image-guided fine-needle aspiration (FNA) or core needle biopsy (CNB) is considered an alternative diagnostic option.

Objective: To assess the diagnostic accuracy and safety of ultrasound (US)-guided core needle biopsy (CNB) in patients with lymphoma.

View Article and Find Full Text PDF

Background: The lack of standardization in risk stratification systems (RSSs) has led to uncertainty in selecting the most effective RSS for diagnosing malignancy risk in thyroid nodules. Therefore, the aim of this study was to compare the diagnostic performance of four current score-based RSSs according to thyroid nodule size, with the goal of determining the most effective RSS and aiding in clinical decision-making.

Methods: Between July 2013 and January 2019, a total of 2,667 consecutive patients presenting with 3,944 thyroid nodules were pathologically diagnosed after thyroidectomy and/or ultrasound (US)-guided fine-needle aspiration (FNA).

View Article and Find Full Text PDF

Ultrasound (US)-guided fine-needle aspiration (FNA) is a minimally invasive procedure that can be performed by an in-training pulmonologist. This is a retrospective study of 73 patients who underwent US-guided FNA by pulmonologist and interventional radiologist. Comparable diagnostic yield was found in this study (88.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!